Drugs and Pharmaceuticals Archives - Page 7 of 14

Pharma companies gain competitive advantage from 1 day Masterclass on Artificial Intelligence in Pharma sales and marketing

Eularis / August 2, 2016

NEW YORK, N.Y. — Eularis announces the release of their one-day Masterclass “Using Artificial Intelligence to Transform Sales and Revenue: What Pharma Need to Know.” Many Pharma sales and marketing teams do not understand the relevance, nor the critical importance, of AI to achieve stronger results in their roles, and believe it is not relevant to them or their job. This is an incorrect assumption.

Drugs and Pharmaceuticals, Free News Articles, Legal and Law, Opinion and Commentary

Sarasota Attorney M David Shapiro Comments on Landmark $70 Million ADHD Drug Risperdal Lawsuit

Shapiro Goldman Babboni and Walsh / July 28, 2016

SARASOTA, Fla. — The Sarasota Florida attorney commented after a Philadelphia jury returned a verdict of $70 million against Johnson and Johnson for failing to warn of the risks associated for taking Risperdal. The case involved a sixteen-year-old boy who developed breast from the medication prescribed for attention deficit disorder (ADHD).

Business, Drugs and Pharmaceuticals, Medical

Paragon BioTeck Signs Exclusive Distribution Agreement with Horus Pharma for Ilast

newsdesk / October 9, 2013

freeNewsArticles Story Summary: Paragon BioTeck, Inc. signs a distribution agreement with Horus Pharma for rights to supply the Ilast range of its medical-grade ocular hygiene and lid care products within the United States. It begins on an exclusive basis this month.

Drugs and Pharmaceuticals

Heart Imaging Technologies Wins $2.5M NIH Grant for Clinical Trials

newsdesk / September 4, 2013

freeNewsArticles Story Summary: Heart Imaging Technologies (HeartIT), the global leader that pioneered the first FDA approved zero-footprint medical imaging workstation, announced today that it has received a $2.5M grant from the National Institutes of Health in order to develop the ‘Cloud Based Corelab of the Future.’

Business, Drugs and Pharmaceuticals

Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine

newsdesk / April 19, 2013

freeNewsArticles Story Summary: Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license agreement for Bausch + Lomb to commercialize and distribute Paragon’s phenylephrine in the United States on an exclusive basis beginning this month.

Drugs and Pharmaceuticals

CMI’s Paul Gondek and Alisa Hamilton to Co-Present with Deanna Schwarz of Pfizer at 2013 PRMG Annual National Conference

newsdesk / March 7, 2013

freeNewsArticles Story Summary: CMI and Pfizer Inc. (NYSE:PFE) will co-present ‘Engaging Stakeholders with A Story – 3 Tips to Improve Research Reporting’ at the PMRG’s upcoming National Annual Conference March 10-12, 2013 in National Harbor, Maryland.

Drugs and Pharmaceuticals, Management Changes

CMI Further Strengthens Pharmaceutical Practice with Addition of Qualitative Leader

newsdesk / February 7, 2013

freeNewsArticles Story Summary: CMI Research, a leader in marketing research services and insight, announced today that Beth Thompson has joined as Vice President, Qualitative Research. Thompson brings a 20-year track record of successfully conducting highly complex domestic and global marketing research.

Drugs and Pharmaceuticals

From Hangovers to Head Lice: What Do Head Lice and Hangovers Have in Common? CT-based Healthcare Entrepreneur George Coleman

newsdesk / July 2, 2012

freeNewsArticles Story Summary: In the early 1980’s George Coleman, head of Dermedics Laboratories in Bridgeport, Conn., teamed up with the former Keneric Industries to reformulate and market an over-the-counter pharmaceutical product designed to treat the symptoms of hangovers. The product, Dr. Seltzer’s Hangover Helper, went on to become the best-selling hangover remedy in the U.S. It was eventually sold to a well-known manufacturer and, after almost 20 years on the market, was discontinued when that manufacturer was sold.

Business, Drugs and Pharmaceuticals

Belvidere Pharmacy, Custom Medicine Makers, Moves to New, and Even Better, Home

newsdesk / February 1, 2012

freeNewsArticles Story Summary: 2012 marks an important milestone for Belvidere Pharmacy. It opened new doors in its new hometown of Highland Park. When owner and President Shara Rudner, R.Ph. took the reins of the business in 1996, it was a typical retail pharmacy stocked with everything from school to surgical supplies. But from the beginning, Belvidere’s staff handled requests for compounded, or custom-made, medications from veterinarians, physicians and specialists.

Drugs and Pharmaceuticals, Medical

Reaction Biology Corporation Unveils Largest Kinase Profiling Data Set in Nature Biotechnology Publication

newsdesk / October 30, 2011

freeNewsArticles Story Summary: Reaction Biology Corporation (‘RBC’) today announced the publication in Nature Biotechnology, of the largest kinase profiling data set in the public domain, disclosing previously unknown kinase inhibition relationships. The data set was compiled from over 100,000 independent activity assays performed with RBC’s proprietary HotSpot(SM) technology.